Essex Bio-Technology Limited (1061.HK)
HKD 2.76
(0.37%)
HKD 2.76
(0.37%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.82 Billion HKD | 4.25% |
| 2022 | 2.71 Billion HKD | -5.27% |
| 2021 | 2.86 Billion HKD | 18.26% |
| 2020 | 2.42 Billion HKD | 16.53% |
| 2019 | 2.07 Billion HKD | 43.34% |
| 2018 | 1.44 Billion HKD | 25.0% |
| 2017 | 1.15 Billion HKD | 24.27% |
| 2016 | 933.29 Million HKD | 46.61% |
| 2015 | 636.57 Million HKD | 26.55% |
| 2014 | 503.04 Million HKD | 29.98% |
| 2013 | 387.01 Million HKD | 16.66% |
| 2012 | 331.74 Million HKD | 52.25% |
| 2011 | 217.89 Million HKD | 28.79% |
| 2010 | 169.19 Million HKD | 29.66% |
| 2009 | 130.49 Million HKD | -29.83% |
| 2008 | 185.97 Million HKD | 30.85% |
| 2007 | 142.12 Million HKD | 56.68% |
| 2006 | 90.7 Million HKD | 19.55% |
| 2005 | 75.87 Million HKD | 47.75% |
| 2004 | 51.35 Million HKD | 13.73% |
| 2003 | 45.15 Million HKD | -38.72% |
| 2002 | 73.68 Million HKD | 13.47% |
| 2001 | 64.93 Million HKD | 105.06% |
| 2000 | 31.66 Million HKD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 2.96 Billion HKD | 0.0% |
| 2023 FY | 2.82 Billion HKD | 4.25% |
| 2023 Q2 | 2.82 Billion HKD | 0.0% |
| 2023 Q4 | 2.82 Billion HKD | 0.0% |
| 2022 Q2 | 2.79 Billion HKD | 0.0% |
| 2022 FY | 2.71 Billion HKD | -5.27% |
| 2022 Q4 | 2.71 Billion HKD | 0.0% |
| 2021 Q2 | 2.61 Billion HKD | 0.0% |
| 2021 Q4 | 2.86 Billion HKD | 0.0% |
| 2021 FY | 2.86 Billion HKD | 18.26% |
| 2020 Q2 | 1.85 Billion HKD | 0.0% |
| 2020 FY | 2.42 Billion HKD | 16.53% |
| 2020 Q4 | 2.42 Billion HKD | 0.0% |
| 2019 Q4 | 2.07 Billion HKD | 0.0% |
| 2019 Q2 | 1.64 Billion HKD | 0.0% |
| 2019 FY | 2.07 Billion HKD | 43.34% |
| 2018 Q2 | 1.38 Billion HKD | 0.0% |
| 2018 Q4 | 1.44 Billion HKD | 0.0% |
| 2018 FY | 1.44 Billion HKD | 25.0% |
| 2017 FY | 1.15 Billion HKD | 24.27% |
| 2017 Q2 | 1.04 Billion HKD | 0.0% |
| 2017 Q4 | 1.15 Billion HKD | 0.0% |
| 2016 Q4 | 933.29 Million HKD | 0.0% |
| 2016 Q2 | 823.68 Million HKD | 0.0% |
| 2016 FY | 933.29 Million HKD | 46.61% |
| 2015 Q4 | 636.57 Million HKD | 0.0% |
| 2015 Q2 | 551.92 Million HKD | 0.0% |
| 2015 FY | 636.57 Million HKD | 26.55% |
| 2014 Q2 | 445.63 Million HKD | 0.0% |
| 2014 Q4 | 503.04 Million HKD | 0.0% |
| 2014 FY | 503.04 Million HKD | 29.98% |
| 2013 Q4 | 387.01 Million HKD | 0.0% |
| 2013 FY | 387.01 Million HKD | 16.66% |
| 2013 Q2 | 372.48 Million HKD | 0.0% |
| 2012 Q4 | 331.74 Million HKD | 0.0% |
| 2012 FY | 331.74 Million HKD | 52.25% |
| 2012 Q2 | 278.69 Million HKD | 0.0% |
| 2011 FY | 217.89 Million HKD | 28.79% |
| 2011 Q4 | 217.89 Million HKD | 0.0% |
| 2011 Q2 | 184.39 Million HKD | 0.0% |
| 2010 Q2 | 138.6 Million HKD | 0.0% |
| 2010 FY | 169.19 Million HKD | 29.66% |
| 2009 FY | 130.49 Million HKD | -29.83% |
| 2008 FY | 185.97 Million HKD | 30.85% |
| 2007 FY | 142.12 Million HKD | 56.68% |
| 2006 FY | 90.7 Million HKD | 19.55% |
| 2005 FY | 75.87 Million HKD | 47.75% |
| 2004 FY | 51.35 Million HKD | 13.73% |
| 2003 FY | 45.15 Million HKD | -38.72% |
| 2002 FY | 73.68 Million HKD | 13.47% |
| 2001 FY | 64.93 Million HKD | 105.06% |
| 2000 FY | 31.66 Million HKD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 907.46 Million HKD | -211.589% |
| Grand Pharmaceutical Group Limited | 22.51 Billion HKD | 87.442% |
| Extrawell Pharmaceutical Holdings Limited | 1.28 Billion HKD | -119.669% |
| Wai Yuen Tong Medicine Holdings Limited | 2.09 Billion HKD | -34.96% |
| Qianhai Health Holdings Limited | 478.11 Million HKD | -491.395% |
| Lee's Pharmaceutical Holdings Limited | 2.89 Billion HKD | 2.183% |
| Tongfang Kontafarma Holdings Limited | 1.72 Billion HKD | -63.695% |
| PuraPharm Corporation Limited | 843.96 Million HKD | -235.033% |
| SSY Group Limited | 11.96 Billion HKD | 76.371% |
| JBM (Healthcare) Limited | 1.38 Billion HKD | -103.612% |
| Jacobson Pharma Corporation Limited | 3.48 Billion HKD | 18.908% |
| China Resources Pharmaceutical Group Limited | 271.69 Billion HKD | 98.959% |